Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

Innovative Binary Options Broker

 

Enter Stock Symbol:  

Incyte Corporation (INCY)

81.10 +0.12 (+0.15%)

8/31/2016  4:00pm

Open:

81.11

Pre. Close:

80.98

High:

82.16

Low:

80.15

Volume:

1,218,743

Market Cap:

15.25B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

83.1 - 84.6

84.6 - 85.82

Low:

77.28 - 78.55

78.55 - 79.58

Close:

79.15 - 81.68

81.68 - 83.73

Technical analysis  (as of: 2016-08-31 4:42:31 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 100.69     One year: 108.41

Support:

Support1: 75.52    Support2: 62.83

Resistance:

Resistance1: 86.21    Resistance2: 92.82

Pivot:

80.02

Moving Averages:

MA(5): 80.91     MA(20): 81.96

MA(100): 80.42     MA(250): 89.57

MACD:

MACD(12,26): -1.01     Signal(12,26,9): -1.09

%K %D:

%K(14,3): 42.78     %D(3): 38.54

RSI:

RSI(14): 46.63

52-Week:

High: 133.62  Low: 55.00  Change(%): -30.1

Average Vol(K):

3-Month: 1100  10-Days 1483

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
INCY has closed below upper band by 37.3%. Bollinger Bands are 28% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 30 Aug 2016 15:56:15 GMT
Top Earnings to Watch for: Incyte Corporation (NASDAQ:INCY)

Thu, 11 Aug 2016 14:37:30 GMT
Better Buy: Inovio Pharmaceuticals, Inc. vs. Incyte Corporation

Sat, 27 Aug 2016 10:18:45 GMT
Incyte Corporation (NASDAQ:INCY): Updated Analyst Ratings

Wed, 24 Aug 2016 14:26:15 GMT
Recent analysts Ratings: Incyte Corporation (NASDAQ:INCY)

Tue, 09 Aug 2016 11:15:00 GMT
Incyte Corporation Q2 Earnings Climb 271%

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

188.00

Shares Float (M)

163.68

% Held by Insiders

11.37

% Held by Institutions

86.50

Shares Short (K)

4850

Shares Short Prior Month (K)

4510

Stock Financials

EPS

0.370

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

1.580

PEG Ratio

8.03

Profit Margin

7.87

Operating Margin

15.71

Return on Assets (ttm)

7.9

Return on Equity (ttm)

42.1

Qtrly Rev. Growth

51.1

Gross Profit (p.s.)

3.866

Sales Per Share

5.007

EBITDA (p.s.)

0.861

Qtrly Earnings Growth

270.40

Operating Cash Flow (M)

192.84

Levered Free Cash Flow (M)

75.58

Valuation

P/E

219.19

P/E Growth Ratio

P/BV

51.33

P/S

16.20

P/CF

79.06

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

2

 

(c) 2006-2013 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.